HCW Biologics (HCWB) Preferred Dividend Payments (2020 - 2021)
HCW Biologics' (HCWB) quarterly Preferred Dividend Payments came in at $482662.0 in Q2 2021, up 72.51% YoY from $279786.0 in Q2 2020, and up 1.11% on a QoQ basis from $477358.0 in Q1 2021.
HCW Biologics (HCWB) Preferred Dividend Payments (2020 - 2021) Analysis & Trends
HCW Biologics (HCWB) has 2 years of Preferred Dividend Payments data on file, last reported at $482662.0 in Q2 2021.
- Quarterly Preferred Dividend Payments rose 72.51% year-over-year to $482662.0 in Q2 2021, while the trailing twelve-month figure through Jun 2022 was $960020.0 (down 42.59% YoY) and the FY2020 annual result came in at $1.3 million, changed N/A from the prior year.
- Preferred Dividend Payments grew to $482662.0 in Q2 2021, from $477358.0 in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $482662.0 in Q2 2021 to a low of $279786.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | HCW Biologics | 2.86 Mn | 2.11 Mn | -93,887.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 482,662.00 |
| Mar 31, 2021 | 477,358.00 |
| Dec 31, 2020 | 429,242.00 |
| Sep 30, 2020 | 282,861.00 |
| Jun 30, 2020 | 279,786.00 |